Dengue Testing Market Size, Trends, Analysis, and Outlook By Product (ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, Others), By End-User (Hospitals, Diagnostic Centers, Others), by Country, Segment, and Companies, 2024-2032

Dengue Testing Market Size, Trends, Analysis, and Outlook By Product (ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, Others), By End-User (Hospitals, Diagnostic Centers, Others), by Country, Segment, and Companies, 2024-2032

The global Dengue Testing market size is poised to register 4.9% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Dengue Testing market across By Product (ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, Others), By End-User (Hospitals, Diagnostic Centers, Others)

With the increasing incidence of dengue fever outbreaks and the growing burden of arboviral diseases transmitted by Aedes mosquitoes in tropical and subtropical regions, there is a rising demand for diagnostic tests that enable rapid and accurate detection of dengue virus infection, facilitating early diagnosis and clinical management of dengue patients and outbreak surveillance activities. Market growth is driven by factors such as expanding urbanization and population mobility, rising awareness of dengue prevention and control measures, and advancements in serological and molecular diagnostic assays for dengue virus detection. Additionally, the expanding applications of point-of-care and rapid diagnostic tests (RDTs), as well as the development of multiplex PCR and nucleic acid amplification-based assays for simultaneous detection of dengue virus serotypes and co-infections with other arboviruses, contribute to market expansion. Further, the emphasis on vector control, community engagement, and public health preparedness for dengue outbreaks, along with efforts to improve laboratory capacity and diagnostic algorithm algorithms for dengue diagnosis and case management, is expected to further propel market growth in the coming years.

Dengue Testing Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Dengue Testing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Dengue Testing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Dengue Testing industry.

Key market trends defining the global Dengue Testing demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Dengue Testing Market Segmentation- Industry Share, Market Size, and Outlook to 2032

The Dengue Testing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Dengue Testing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Dengue Testing industry

Leading Dengue Testing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Dengue Testing companies.

Dengue Testing Market Study- Strategic Analysis Review

The Dengue Testing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-

• Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
• Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
• Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
• Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.

Dengue Testing Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Dengue Testing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.

Dengue Testing Country Analysis and Revenue Outlook to 2032

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.

North America Dengue Testing Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Dengue Testing market segments. Similarly, Strong market demand is encouraging Canadian Dengue Testing companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Dengue Testing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Dengue Testing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Dengue Testing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Dengue Testing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Dengue Testing Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Dengue Testing in Asia Pacific. In particular, China, India, and South East Asian Dengue Testing markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.

Latin America Dengue Testing Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Dengue Testing Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Dengue Testing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Dengue Testing.

Dengue Testing Market Company Profiles

The global Dengue Testing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories, Abnova Corp, Certest Biotec SL, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, Immundiagnostik AG, InBios International Inc, NovaTec Immundiagnostica GmbH, OriGene Technologies Inc, PerkinElmer Inc, Quest Diagnostics Inc, Thermo Fisher Scientific Inc.

Recent Dengue Testing Market Developments

The global Dengue Testing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Dengue Testing Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis

• Pricing Analysis
• Value Chain Analysis
• SWOT Profile
• Market Dynamics- Trends, Drivers, Challenges
• Porter’s Five Forces Analysis
• Macroeconomic Impact Analysis
• Case Scenarios- Low, Base, High

Market Segmentation:

By Product

ELISA-based Tests

RT-PCR based Tests

Dengue IgG/IgM Rapid Test

Others

By End-User

Hospitals

Diagnostic Centers

Others

Geographical Segmentation:

• North America (3 markets)
• Europe (6 markets)
• Asia Pacific (6 markets)
• Latin America (3 markets)
• Middle East Africa (5 markets)

Companies

Abbott Laboratories

Abnova Corp

Certest Biotec SL

DiaSorin S.p.A.

F. Hoffmann-La Roche Ltd

Immundiagnostik AG

InBios International Inc

NovaTec Immundiagnostica GmbH

OriGene Technologies Inc

PerkinElmer Inc

Quest Diagnostics Inc

Thermo Fisher Scientific Inc

Formats Available: Excel, PDF, and PPT